Drug · DIN 02413639
BACLOFEN INJECTION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 11, 2018; first marketed June 6, 2014.
- Drug Identification Number (DIN)
- 02413639
- Company (DIN owner)
- Sterimax Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intrathecal
- Therapeutic class (ATC)
- Baclofen M03BX01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BACLOFEN | 10 MG | 20 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 11, 2018: NOC 20300Abbreviated New Drug Submission (ANDS) · Transfer of drug identification numbers
- November 17, 2014: NOC 16307Abbreviated New Drug Submission (ANDS) · Merger - buyout
- May 2, 2014: NOC 15571Abbreviated New Drug Submission (ANDS) · Transfer of drug identification number
- October 10, 2013: NOC 14800Abbreviated New Drug Submission (ANDS)
Other DINs named BACLOFEN INJECTION
- DIN 02413620 · Marketed
- DIN 02413647 · Marketed
- DIN 02457075 · Marketed
- DIN 02457059 · Dormant
- DIN 02457067 · Dormant